After 40 years in limbo: Styrene is probably carcinogenic

June 1, 2018, Aarhus University

For 40 years, researchers have believed there is an increased risk of cancer associated with styrene. Now, a working group under the auspices of the WHO and appointed by the International Agency for Research on Cancer (IARC), has upgraded this warning from "possibly carcinogenic" to "probably carcinogenic" for humans, and the decision is largely based on register-based studies from Aarhus, together with new animal evidence.

The new announcement from the World Health Organisation is authored by 23 handpicked researchers from around the world, including Professor Henrik Kolstad. He is professor in occupational medicine, at the Department of Clinical Medicine at Aarhus University as well as Aarhus University Hospital.

"The reason for my presence in the working group is our register-based research, which is unique throughout the world, and where the most recent styrene study shows the risk of acute myeloid leukaemia, a rare form of leukemia, is doubled. Out of the more than 70,000 people included in the research project, we found 25 cases of , where you would statistically expect to find 10," says Professor Henrik Kolstad with reference to the research article 'Styrene exposure and risk of lymphohematopoietic malignancies in 73,036 reinforced plastics workers', published in Epidemiology.

Another important research result is a fivefold risk for a particular type of nasal cancer following styrene exposure. This part of the study is published in Occupational and Environmental Medicine in the article "Sinonasal adenocarcinoma following styrene exposure in the reinforced plastics industry."

Styrene is included in synthetic rubber, some insulation materials, disposable tableware, packaging and fiberglass plastic.

In March, the 23 researchers in the WHO working group spent 10 intensive working days in Lyon, where they had the task of reviewing and re-evaluating the carcinogenic risk based on the latest research on styrene exposure which includes epidemiological studies of humans together with animal experiments and what are known as mechanism studies. The latter cover cause-effect studies based on biological material.

The issue of styrene and cancer has been a priority for IARC ever since an accumulation of leukaemia cases among employees in the American synthetic rubber industry observed in the 1970s. However, it was not possible to establish whether the American workers contracted leukaemia from handling styrene or from the chemical butadiene, a constituent in the production of synthetic rubber—and this is where the Danish register-based studies come into the picture.

"Clearly, the best place to study the possible health effects of styrene exposure is in the reinforced plastics industry, where no butadiene is involved. We have therefore mapped the cancer incidence for those who worked in companies that used styrene in the production during the period 1968-2011," explains Henrik Kolstad on the background for what has ended up being the world's largest epidemiological study of styrene exposure in the reinforced plastics industry.

In the research project, Ph.D. student Mette Skovgaard Christensen, Henrik Kolstad and their research colleagues followed 73,036 employees who during the period 1968-2011 worked in one of the 456 small and medium-sized companies in Denmark that have used styrene in the production of e.g. wind turbines or yachts.

The study involved a comprehensive linkage of registers in which the researchers used the central business register, along with various other company registers, to identify the relevant companies and their employees. After this stage, the information was linked with the Danish Cancer Register to assess the incidences of different types of cancer among the employees compared to the general population's risk of developing the same diseases.

One of the reasons why the results carry a lot of weight with the WHO is that Kolstad and his colleagues have been able to compare the research data from the cancer patients with measurements of styrene exposure in the Danish reinforced plastics industry over time.

"That part of the study is primarily based on measurements that the Danish Working Environment Authority carried out a number of years ago, since the Danish Working Environment Authority has not carried out measurements of over the past several years. Many companies take measurements, but they are not publicly available. We've requested the relevant data in anonymised form from the companies that analyse the measurements , but unfortunately, we were unable to gain access to them," says Henrik Kolstad

"This is deeply regrettable, because the fact is that good answers to important questions presupposes that we also have access to the relevant information in the future."

Henrik Kolstad emphasizes that the Danish register findings reflect the sins of the past. Significant improvements have been made to the working environments in the Danish reinforced in recent years, but globally the problem has not been solved.

Explore further: Limited evidence that styrene, a high volume plastics chemical and animal carcinogen, causes cancer in humans

More information: Mette Skovgaard Christensen et al, Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers, Epidemiology (2018). DOI: 10.1097/EDE.0000000000000819

Related Stories

Limited evidence that styrene, a high volume plastics chemical and animal carcinogen, causes cancer in humans

February 14, 2017
In 2011, the styrene, a high volume plastics chemical and animal carcinogen, was the focal point in a 'poison scandal' in the Danish media; but now a registry study of more than 72,000 employees from more than 400 companies ...

Chemical in foam cups again seen as likely cancer cause

July 29, 2014
The National Research Council Monday reaffirmed that styrene - the key chemical component of foam cups and other food service items - may cause cancer in people.

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.